Clinical Trial Update: Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating novel targeted drugs combined with the R-ICE regimen for relapsed or refractory diffuse large B-cell lymphoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING